Abstract
BACKGROUND: Natural killer (NK) cells are a key component of innate immunity; their activity is modulated by cytokines and hormones and is influenced by diet. In obesity, a higher risk of cancer and infections has been demonstrated. Studies on NK cell activity have yielded inconsistent results; NK cell sensitivity to modulators has not been assessed before.
OBJECTIVE: In this case–control study, we assessed both spontaneous NK cell activity and responsiveness to positive (interleukin (IL)-2) and negative (cortisol) modulators in uncomplicated obesity; we searched for correlations between NK cell activity and anthropometric, dietary and metabolic variables.
METHODS: In all, 21 obese (six males/15 females) and 21 age- and sex-matched healthy nonobese subjects underwent clinical examination and dietary and laboratory analyses. Spontaneous and modulated NK activities of peripheral blood mononuclear cells were measured by enzyme-release cytotoxicity assay.
RESULTS: Spontaneous NK cell activity was not different in obese subjects vs controls. IL-2 stimulated and cortisol inhibited NK cell activity in both populations. Cortisol-dependent inhibition was lower in the obese than in the control group (−24.4±2.9 vs −38.6±3.3%, P=0.002), but decreased sensitivity was restricted to women (P=0.0007). In obese subjects, cortisol-dependent inhibition negatively correlated with serum leptin levels (r=−0.54, P=0.02) and, in women, with body mass index (r=−0.63, P=0.01); IL-2-dependent stimulation positively correlated with dietary carbohydrates (r=0.61, P=0.005) and serum LDL levels (r=0.55, P=0.009) and negatively correlated with dietary lipids (r=−0.71, P=0.0006).
CONCLUSION: Spontaneous and IL-2-inducible NK cell activity is normal in uncomplicated obesity. Sensitivity to IL-2 correlates with fat and carbohydrate intake. Sensitivity to glucocorticoids negatively correlates with serum leptin levels and is significantly diminished in obese women, in whom it correlates with body mass index.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L . What is a natural killer cell? Nat Immunol 2002; 3: 6–8.
Seaman WE . Natural killer cells and natural killer T cells. Arthritis Rheum 2000; 6: 1204–1217.
Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP . Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189–220.
Curran EM, Berghaus LJ, Vernetti NJ, Saporita AJ, Lubahn DB, Estes DM . Natural killer cells express estrogen receptor-alpha and estrogen receptor-beta and can respond to estrogen via a non-estrogen receptor-alpha-mediated pathway. Cell Immunol 2001; 214: 12–20.
Gan X, Zhang L, Solomon GF, Bonavida B . Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Brain Behav Immun 2002; 16: 227–246.
Jonsdottir IH . Exercise immunology: neuroendocrine regulation of NK-cells. Int J Sports Med 2000; 21 (Suppl 1): S20–S23.
Chiappelli F, Yamashita N, Faisal M, Kemeny M, Bullington R, Nguyen L, Clement LT, Fahey JL . Differential regulation of three human cytotoxic cell populations by β-endorphin. Int J Immunopharmacol 1991; 13: 291–297.
Chiappelli F, Franceschi C, Ottaviani E, Solomon GF, Tsylor AN . Neuroendocrine modulation of the immune system. In: Greger R, Koepken HP, Moomarets W, Winhorst U (eds) Human physiology: from cellular mechanisms to integration. Springer Verlag: New York, 1996, pp 1707–1729.
Gatti G, Cavallo R, Sartori ML, Del Ponte D, Masera R, Salvadori A, Carignola R, Angeli A . Inhibition by cortisol of human natural killer (NK) cell activity. J Steroid Biochem 1987; 26: 49–58.
Gatti G, Masera RG, Pallavicini L, Sartori ML, Staurenghi A, Orlandi F, Angeli A . Interplay in vitro between ACTH, β-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity. Brain Behav Immun 1993; 7: 16–28.
Besedovsky H, Del Rey A . Immuno-neuroendocrine interactions: facts and hypotheses. Endocr Rev 1996; 17: 485–496.
Masera RG, Staurenghi A, Sartori ML, Angeli A . Natural killer (NK) cell activity in Cushing's syndrome. Eur J Endocrinol 1999; 140: 299–306.
Masera RG, Prolo P, Sartori ML, Staurenghi A, Griot G, Ravizza L, Dovio A, Chiappelli F, Angeli A . Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease. Psychoneuroendocrinology 2002; 27: 447–461.
Yaqoob P, Newsholme EA, Calder PC . Inhibition of natural killer cell activity by dietary lipids. Immunol Lett 1994; 41: 241–247.
Pedersen BK, Helge JW, Richter EA, Rohde T, Kiens B . Training and natural immunity: effects of diets rich in fat or carbohydrate. Eur J Appl Physiol 2000; 82: 98–102.
Rasmussen LB, Kiens B, Pedersen BK, Richter EA . Effect of diet and plasma fatty acid composition on immune status in elderly men. Am J Clin Nutr 1994; 59: 572–577.
Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA, Calder PC . Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001; 36: 1183–1193.
Staurenghi A, Masera RG, Prolo P, Griot G, Sartori ML, Ravizza L, Angeli A . Hypothalamic–pituitary–adrenal axis function, psychopathological traits, and natural killer (NK) cell activity in anorexia nervosa. Psychoneuroendocrinology 1997; 22: 575–590.
WHO MONICA Project. Risk factors. Int J Epidemiol 1989; 18 (3 Suppl 1): S46–S55.
Forster KR, Lukaski HC . Whole body impedance—what does it measure? Am J Clin Nutr 1996; 64 (3 Suppl): 388S–396S.
Khaodhiar L, McCowen KC, Blackburn GL . Obesity and its comorbid conditions. Clin Cornerstone 1999; 2: 17–31.
Bjorntorp P . Neuroendocrine perturbations as a cause of insulin resistance. Diabetes Metab Res Rev 1999; 15: 427–441.
Lamas O, Marti A, Martinez JA . Obesity and immunocompetence. Eur J Clin Nutr 2002; 56 (Suppl 3): S42–S45.
Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE, Fagoaga OR . Influence of obesity on immune function. J Am Diet Assoc 1999; 99: 294–299.
Clinton SK, Giovannucci EL . Nutrition in the aetiology and prevention of cancer. In: Holland JF, Bast Jr RC, Morton DL, Frei III E, Kufe DW, Weichselbaum RR (eds) Cancer medicine, Vol 1. Williams and Wilkins: Baltimore, 1997, pp 465–494.
Schmidt MI, Duncan BB . Diabesity: an inflammatory metabolic condition. Clin Chem Lab Med 2003; 41: 1120–1130.
Lyon CJ, Law RE, Hsueh WA . Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003; 144: 2195–2200.
Nieman DC, Nehlsen-Cannarella SI, Henson DA, Butterworth DE, Fagoaga OR, Warren BJ, Rainwater MK . Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord 1996; 20: 353–360.
Scanga CB, Verde TJ, Paolone AM, Andersen RE, Wadden TA . Effects of weight loss and exercise training on natural killer cell activity in obese women. Med Sci Sports Exerc 1998; 30: 1666–1671.
Santagostino A, Garbaccio G, Pistorio A, Bolis V, Camisasca G, Pagliaro P, Girotto M . An Italian national multicenter study for the definition of reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults. Haematologica 1999; 84: 499–504.
Moriguchi S, Oonishi K, Kato M, Kishino Y . Obesity is a risk factor for deteriorating cellular immune functions decreased with aging. Nutr Res 1995; 15: 151–160.
Nieman DC, Henson DA, Gusewitch G, Warren BJ, Dotson RC, Butterworth DE, Nehlsen-Cannarella SL . Physical activity and immune function in elderly women. Med Sci Sports Exerc 1993; 25: 823–831.
Williamson DF, Kahn HS, Worthman CM, Burnette JC, Russel CM . Precision of anthropometry. Am J Hum Biol 1993; 5: 159–167.
Boyum A . Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 1976; 5 (Suppl 5): 9–15.
Korzeniewski C, Callewaert DM . An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983; 25: 313–320.
Decker T, Lohmann-Matthes ML . A quick and simple method for quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988; 115: 61–69.
Konjevic G, Jurisic V, Spuzic I . Corrections to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity. J Immunol Methods 1997; 200: 199–201.
Pross HF, Baines MG, Rubin P, Schragge P, Patterson MS . Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of human natural killer cell activity. J Clin Immunol 1981; 1: 51–63.
Rothman KJ . No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43–46.
Øgard CG, Bratholm P, Kristensen LØ, Almdal T, Christensen NJ . Lymphocyte glucocorticoid receptor mRNA correlates negatively to serum leptin in normal weight subjects. Int J Obes Relat Metab Disord 2000; 24: 915–919.
Moretta L, Biassoni R, Bottino C, Mingari MC, Moretta A . Surface receptors that regulate the NK cell function: beyond the NK cell scope. Curr Top Microbiol Immunol 2002; 266: 11–22.
Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L . Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19: 197–223.
Vettor R, Macor C, Novo F, Gottardo C, Zovato S, Simoncini M, Federspil G, Armanini D . Corticosteroid receptors in mononuclear leucocytes of obese subjects. J Endocrinol 1998; 156: 187–194.
Güven M, Hatemi H, Tasan E, Altuntas Y, Ulutin T, Tezcan V, Kanigür-Sultuybek G . The modulation of glucocorticoid receptor content by 3-O-methyl-D-glucose transport in human mononuclear leukocyte in obesity. J Endocrinol Invest 1998; 21: 656–661.
Laudet V, Gronemeyer H . GR. In: Laudet V, Gronemeyer H (eds) The nuclear receptor factsbook. Academic Press: London, San Diego, 2002, pp 345–367.
Brentani MM, Wajchenberg BL, Cesar FP, Martins VR . Regulation of the glucocorticoid receptor by glucocorticoids in human mononuclear leukocytes. Horm Res 1986; 24: 9–17.
Junker K . Glucocorticoid receptor of human mononuclear luekocytes in vitro. J Clin Endocrinol Metab 1983; 57: 506–512.
De Sanctis JB, Blanca I, Bianco NE . Expression of different lipoprotein receptors in natural killer cells and their effects on natural killer proliferative and cytotoxic activity. Immunology 1995; 86: 399–407.
De Sanctis JB, Blanca I, Radzioch D, Bianco NE . Expression and function of low-density lipoprotein receptors in CD3−CD16+CD56+ cells: effect of interleukin 2. Cell Immunol 1996; 167: 18–29.
Malorni W, Straface E, Di Genova G, Fattorossi A, Rivabene R, Camponeschi B, Masella R, Viora M . Oxidized low-density lipoproteins affect natural killer cell activity by impairing cytoskeleton function and altering the cytokine network. Exp Cell Res 1997; 236: 436–445.
Acknowledgements
This work was supported by grants from the Ministero dell'Università e della Ricerca Scientifica, Cassa di Risparmio di Cuneo, Cassa di Risparmio di Saluzzo and Fondazione Rossini.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dovio, A., Caramello, V., Masera, R. et al. Natural killer cell activity and sensitivity to positive and negative modulation in uncomplicated obese subjects: relationships to leptin and diet composition. Int J Obes 28, 894–901 (2004). https://doi.org/10.1038/sj.ijo.0802639
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802639